- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03012152
A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction
A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction Among Egyptian Females
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This planned study was conducted on 70 female patients presented to our tertiary referral breast unit at Ain Shams University hospitals with breast cancer amid the period from September 2012 to May 2013 .
Every one of them signed an informed consent to partake in this study that was approved in a meeting held by the ethical committee on august 2012 at Ain Shams University. All patients sharing in the study received closed envelope before surgery in a randomized way in which the surgical technique is written either standard conservative surgery or oncoplastic surgery(Double Blind).
Our patients were partitioned into 2 equal groups: group A (35patients) who underwent standard conservative surgery, group B (35patients) who underwent oncoplastic surgery.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female Patients with stage 1,2 breast cancer.
Exclusion Criteria:
- Patients >60 years.
- Patients with previous breast surgery.
- patients candidate for mastectomy or palliative excision. Patients with collagen disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard conservative group
Group A (35 patients) have standard curative conservative breast surgery without integration of plastic techniques . . |
|
|
Active Comparator: Oncoplastic group
Group B(35 patients) have curative oncoplastic surgery in which plastic techniques integrated with oncological procedures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Margins in all specimens measured in millimeters 2.
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16379
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breastcancer
-
Centre Leon BerardClaude Bernard UniversityCompleted
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedMetastatic BreastcancerSpain, Ireland, Italy, Switzerland, Slovenia, Belgium
-
The First Affiliated Hospital, Guangzhou University...UnknownMetastatic BreastcancerChina
-
Brugmann University HospitalUnknown
-
Tata Memorial CentreRecruiting
-
University Hospital, GhentActive, not recruiting
-
University of Illinois at ChicagoNational Cancer Institute (NCI); The Resurrection Project; Juan Diego Centro...Completed
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedEstrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative NeoplasmItaly
-
Athenex, Inc.PharmaEssentiaTerminated
Clinical Trials on Standard conservative breast surgery
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting
-
Istituti Clinici Scientifici Maugeri SpARecruiting
-
Institut Català d'OncologiaRecruiting
-
Centre Hospitalier Universitaire de BesançonNot yet recruiting
-
Assiut UniversityUnknown
-
Ain Shams UniversityCompletedNon Metastatic Breast CancerEgypt
-
Assiut UniversityRecruitingSafety of Excision the New Tumor SizeEgypt
-
Ain Shams UniversityCompleted
-
The Hospital of VestfoldOslo University HospitalActive, not recruitingHypertension | Obstructive Sleep Apnea | Morbid Obesity | Osteoarthrosis | Type 2 DMNorway